World news 1M views since yesterday

Targeted migraine treatments offer more headache-free days, Korean report says

A patient describes the disruption at home and work as the report examines preventive medicines and expanded treatment approvals in South Korea.

Channel: YTN ·

South KoreaStory of November 8, 2026Trari Newsroom

Why this story? One of YTN's most watched videos since yesterday, with 1,024,485 views.

YTN: South Korea's first 24-hour news channel, on air since 1995. 5.4M subscribers and 23B views.

편두통 환자에게 생긴 희망...일상 무너뜨리는 통증의 실체 [자막뉴스] / YTN

Park Seul-gi spent much of her time lying down at home. Her husband took on much of the housework, and even when she made it to work, migraines often left her unable to function normally.

Her experience opens a report from South Korea's YTN (Yonhap Television News) on treatments designed specifically for migraine, rather than medicines borrowed from other conditions. The report drew about a million views since yesterday.

Migraine is often misunderstood as simply a headache on one side, the report explains. Attacks can also bring nausea and vomiting, with severe pain lasting for days and interrupting ordinary life.

Kim Byung-kun, a neurology professor at Nowon Eulji Medical Center, explains that older preventive treatments included medicines developed for high blood pressure, depression and epilepsy. Side effects, alongside limited benefit for some patients, made treatment difficult.

The newer approach targets CGRP, a substance involved in migraine. The aim is not only to ease pain during an attack, but to reduce how often attacks occur.

Citing research published in the journal Cephalalgia, the report says seven in ten patients receiving an oral targeted treatment had their monthly migraine days reduced by at least half. Nearly one in five had no migraines during the period assessed. That result describes the study outcome, not a permanent cure.

YTN also reports that an oral targeted medicine gained approval for treating acute attacks in adults the previous week, while approval for a preventive injection was extended to children and adolescents in May. Kim describes the disruption migraine causes to school attendance, including students spending time lying down in the school infirmary.

The report closes with specialists urging patients to seek treatment rather than regard migraine as pain they simply have to endure.

Published on Trari